Mr. Michael Favet is a President, Chief Executive Officer & Director at NeuroPace, Inc. He is on the Board of Directors at Earlens Corp., NeuroPace, Inc. and Favet Living Trust. Mr. Favet was previously employed as a Managing Director by Kck Us, Inc., a Chief Operating Officer by Advanced Cardiac Therapeutics, Inc., a Chief Operating Officer by Sonitus Medical, Inc., a Senior VP-Science, Technology & Operations by Ventus Medical, Inc., a Vice President-Research & Development by Boston Scientific Corp., a Director-Product Development by Cardiac Rhythm Management, a Vice President-Research & Development by Guidant Corp., and a Vice President-Research & Development by MAQUET Cardiovascular LLC. He received his undergraduate degree from the University of Illinois and an MBA from the University of Minnesota.
|03/08/2022||155,080||Award at $0 per share.||0|
|06/04/2021||27,000||Award at $0 per share.||0|
|06/04/2021||26,590||Award at $0 per share.||0|
|04/26/2021||15,385||Award at $0.03 per share.||461|
|04/26/2021||7,562||Derivative/Non-derivative trans. at $0 per share.||0|